A case of acute generalized exanthematous pustulosis following COVID-19 infection and remdesivir.
AGEP
COVID‐19
acute generalized exanthematous pustulosis
adverse reaction
Journal
Clinical case reports
ISSN: 2050-0904
Titre abrégé: Clin Case Rep
Pays: England
ID NLM: 101620385
Informations de publication
Date de publication:
Jun 2023
Jun 2023
Historique:
received:
22
04
2023
revised:
15
05
2023
accepted:
17
05
2023
medline:
1
6
2023
pubmed:
1
6
2023
entrez:
1
6
2023
Statut:
epublish
Résumé
We report a challenging AGEP case following COVID-19 infection and a history of remdesivir use. Our study highlights the importance of considering history of COVID-19 and remdesivir as possible causative factors when visiting new-onset AGEP patients.
Identifiants
pubmed: 37261394
doi: 10.1002/ccr3.7423
pii: CCR37423
pmc: PMC10227198
doi:
Types de publication
Case Reports
Langues
eng
Pagination
e7423Informations de copyright
© 2023 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.
Déclaration de conflit d'intérêts
The authors have no conflict of interest to declare.
Références
Korean J Intern Med. 2021 Nov;36(6):1537-1538
pubmed: 34130372
J Allergy Clin Immunol Pract. 2020 Sep;8(8):2777-2779.e1
pubmed: 32525093
Case Rep Med. 2022 Aug 10;2022:9880827
pubmed: 35991338
Cureus. 2020 Nov 21;12(11):e11609
pubmed: 33240733
Dermatol Ther. 2020 Jul;33(4):e13565
pubmed: 32401410
Curr Allergy Asthma Rep. 2020 Oct 12;20(12):75
pubmed: 33047260
JAAD Case Rep. 2021 Oct;16:96-97
pubmed: 34466640
Dermatol Ther. 2021 Jan;34(1):e14662
pubmed: 33301232
Arch Dermatol Res. 2023 May;315(4):685-697
pubmed: 36319703
Rev Inst Med Trop Sao Paulo. 2021 May 24;63:e42
pubmed: 34037158